应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02511 君圣泰医药-B
交易中 03-23 14:04:25
3.040
-0.020
-0.65%
最高
3.240
最低
3.000
成交量
39.70万
今开
3.070
昨收
3.060
日振幅
7.84%
总市值
17.36亿
流通市值
17.36亿
总股本
5.71亿
成交额
121.57万
换手率
0.07%
流通股本
5.71亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
君圣泰医药-B(02511.HK)拟3月27日举行董事会会议以审批年度业绩
中金财经 · 03-13
君圣泰医药-B(02511.HK)拟3月27日举行董事会会议以审批年度业绩
君圣泰医药-B(02511):HTD1801的新药上市申请获中国国家药品监督管理局受理
智通财经 · 03-10
君圣泰医药-B(02511):HTD1801的新药上市申请获中国国家药品监督管理局受理
君圣泰医药大涨近20%创年内新高 暂四日连升累涨超66%
格隆汇 · 03-10
君圣泰医药大涨近20%创年内新高 暂四日连升累涨超66%
君圣泰医药-B03月06日获主力加仓433.5万元
市场透视 · 03-06
君圣泰医药-B03月06日获主力加仓433.5万元
创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情
金吾财讯 · 03-06
创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情
君圣泰医药-B盘中异动 大幅下挫7.22%
市场透视 · 03-04
君圣泰医药-B盘中异动 大幅下挫7.22%
君圣泰医药(02511)2月无新增发行或股份变动
公告速递 · 03-02
君圣泰医药(02511)2月无新增发行或股份变动
君圣泰医药-B盘中异动 早盘大幅下跌12.99%
市场透视 · 03-02
君圣泰医药-B盘中异动 早盘大幅下跌12.99%
君圣泰医药-B02月26日主力净流出27.5万元 散户资金买入
市场透视 · 02-26
君圣泰医药-B02月26日主力净流出27.5万元 散户资金买入
每日卖空追踪 | 君圣泰医药-B 02月12日卖空量成交2.8万股,卖空比例为13.73%
市场透视 · 02-12
每日卖空追踪 | 君圣泰医药-B 02月12日卖空量成交2.8万股,卖空比例为13.73%
每日卖空追踪 | 君圣泰医药-B 02月09日卖空量成交2500股,卖空比例为1.24%
市场透视 · 02-09
每日卖空追踪 | 君圣泰医药-B 02月09日卖空量成交2500股,卖空比例为1.24%
CKM治疗新纪元:君圣泰医药-B(2511.HK)“一药多效”战略迎来价值重估关键节点
格隆汇 · 02-09
CKM治疗新纪元:君圣泰医药-B(2511.HK)“一药多效”战略迎来价值重估关键节点
君圣泰医药-B(02511)完成HTD1801治疗代谢相关脂肪性肝炎的 IIb期临床研究
智通财经 · 02-05
君圣泰医药-B(02511)完成HTD1801治疗代谢相关脂肪性肝炎的 IIb期临床研究
每日卖空追踪 | 君圣泰医药-B 02月03日卖空量成交1.3万股,卖空比例为3.25%
市场透视 · 02-03
每日卖空追踪 | 君圣泰医药-B 02月03日卖空量成交1.3万股,卖空比例为3.25%
君圣泰医药-B02月03日主力净流出21.3万元 散户资金买入
市场透视 · 02-03
君圣泰医药-B02月03日主力净流出21.3万元 散户资金买入
君圣泰医药(02511)更新2026年1月股份变动月报表,股本维持稳定
公告速递 · 02-02
君圣泰医药(02511)更新2026年1月股份变动月报表,股本维持稳定
君圣泰医药-B(02511)任命Filip Surmont博士为首席医学官 强化心肾代谢系统疾病(CKM)布局
智通财经 · 02-02
君圣泰医药-B(02511)任命Filip Surmont博士为首席医学官 强化心肾代谢系统疾病(CKM)布局
君圣泰医药-B盘中异动 急速下跌7.61%
市场透视 · 01-29
君圣泰医药-B盘中异动 急速下跌7.61%
每日卖空追踪 | 君圣泰医药-B 01月27日卖空量成交1000股,卖空比例为0.86%
市场透视 · 01-27
每日卖空追踪 | 君圣泰医药-B 01月27日卖空量成交1000股,卖空比例为0.86%
君圣泰医药-B01月16日主力净流入23.2万元 散户资金抛售
市场透视 · 01-16
君圣泰医药-B01月16日主力净流入23.2万元 散户资金抛售
加载更多
公司概况
公司名称:
君圣泰医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多靶点疗法。该公司自主开发了多个候选产品的产品管线,涵盖代谢和消化疾病的多种适应症,其中部分产品处于临床阶段。该公司的核心产品HTD1801(小檗碱熊去氧胆酸盐)是一种新分子实体,作为肠肝抗炎代谢调节剂,靶向调节对人体代谢过程中至关重要的多个通路,包括与代谢及消化系统疾病相关的通路。该公司在美国、中国大陆、香港和澳大利亚开展业务。
发行价格:
--
{"stockData":{"symbol":"02511","market":"HK","secType":"STK","nameCN":"君圣泰医药-B","latestPrice":3.04,"timestamp":1774245573658,"preClose":3.06,"halted":0,"volume":397000,"delay":0,"changeRate":-0.006535947712418306,"floatShares":571000000,"shares":571000000,"eps":-0.84452,"marketStatus":"交易中","change":-0.02,"latestTime":"03-23 14:04:25","open":3.07,"high":3.24,"low":3,"amount":1215685,"amplitude":0.078431,"askPrice":3.04,"askSize":34500,"bidPrice":3,"bidSize":220500,"shortable":0,"etf":0,"ttmEps":-0.559,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774253400000},"marketStatusCode":2,"adr":0,"listingDate":1703174400000,"exchange":"SEHK","adjPreClose":3.06,"openAndCloseTimeList":[[1774229400000,1774238400000],[1774242000000,1774252800000]],"volumeRatio":0.616687,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02511","defaultTab":"news","newsList":[{"id":"2619953391","title":"君圣泰医药-B(02511.HK)拟3月27日举行董事会会议以审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2619953391","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619953391?lang=zh_cn&edition=full","pubTime":"2026-03-13 18:07","pubTimestamp":1773396423,"startTime":"0","endTime":"0","summary":"格隆汇3月13日丨君圣泰医药-B(02511.HK)公告,董事会会议将于2026年3月27日(星期五)举行,藉以(其中包括)审议及批准公司及其附属公司截至2025年12月31日止年度经审核全年业绩及其发布,以及处理其他事项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260313/32066952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2618935382","title":"君圣泰医药-B(02511):HTD1801的新药上市申请获中国国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2618935382","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618935382?lang=zh_cn&edition=full","pubTime":"2026-03-10 17:22","pubTimestamp":1773134579,"startTime":"0","endTime":"0","summary":"智通财经APP讯,君圣泰医药-B(02511)发布公告,中国国家药品监督管理局(NMPA)已受理 HTD1801用于治疗2型糖尿病(T2DM)的新药上市申请(NDA)。这是君圣泰医药提交的首个新药上市申请,也是公司迈向产品商业化的重要里程碑。HTD1801已完成3项针对T2DM适应症的多中心、随机、双盲、对照的III期临床研究,均达主要终点和多项次要终点,在血糖、血脂、炎症、肾功能等多个心肾代谢关键维度呈现出一致的改善趋势,充分展现了其一药多效、综合获益的临床价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"君圣泰医药-B(02511):HTD1801的新药上市申请获中国国家药品监督管理局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2618987412","title":"君圣泰医药大涨近20%创年内新高 暂四日连升累涨超66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618987412","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618987412?lang=zh_cn&edition=full","pubTime":"2026-03-10 15:45","pubTimestamp":1773128759,"startTime":"0","endTime":"0","summary":"3月10日,君圣泰医药-B今日高开高走,一度大涨19.25%至3.16港元,股价创年内新高。该股自上周四以来已连续4个交易日上涨,累涨超66%,大幅跑赢大盘及行业表现。消息面上,君圣泰医药今年2月上旬举行投资者会议,系统阐述了其以“一药多效”策略引领心肾代谢系统疾病综合治疗新时代的战略布局,并解读了多项关键临床进展。","market":"us","thumbnail":"http://imgcloud.jrjimg.cn/2026/03/cms_20260310154559501.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2026/03/cms_20260310154559501.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/03/10154556248420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2617483637","title":"君圣泰医药-B03月06日获主力加仓433.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617483637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617483637?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:15","pubTimestamp":1772784918,"startTime":"0","endTime":"0","summary":"03月06日, 君圣泰医药-B股价涨11.63%,报收2.40元,成交金额836.6万元,换手率0.59%,振幅23.72%,量比1.59。君圣泰医药-B今日主力资金净流入433.5万元,连续3日净流入,上一交易日主力净流入33.7万元。该股近5个交易日上涨3.90%,主力资金累计净流入1673.7万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1629.7万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161602a6aa29b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161602a6aa29b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2617066845","title":"创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617066845","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617066845?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:41","pubTimestamp":1772764875,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块强势,三生制药 涨9.83%,基石药业-B涨6.84%,荣昌生物涨6.31%,映恩生物-B涨5.98%,四环医药涨5.76%,恒瑞医药涨5.77%,君圣泰医药-B涨5.58%,康诺亚-B涨5.31%,复宏汉霖涨5.02%。交银国际表示,本周各公司业绩预告陆续发布,该机构建议持续关注财务表现超预期、盈利路径清晰的公司,其业绩兑现有望催化板块行情。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976042","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","HK0000165453.HKD","159992","BK1574","02511","HK0000500386.USD","02696","09606","BK1593","02616","HK0000320264.USD","BK1583","01530","HK0000306701.USD","LU2543165471.USD","LU1969619763.USD","00460","BK1161","LU0359202008.SGD","LU1023057109.AUD","09995","BK1515","HK0000252160.HKD","02162","HK0000306685.HKD","BK1587","BK1191","HK0000252152.HKD","LU0359201612.USD","LU0359201885.HKD","BK1600","06978","HK0000320223.HKD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2617595890","title":"君圣泰医药-B盘中异动 大幅下挫7.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617595890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617595890?lang=zh_cn&edition=full","pubTime":"2026-03-04 09:55","pubTimestamp":1772589333,"startTime":"0","endTime":"0","summary":"2026年03月04日早盘09时55分,君圣泰医药-B股票出现异动,股价急速下挫7.22%。君圣泰医药-B股票所在的药品行业中,整体跌幅为0.36%。其相关个股中,德琪医药-B、开拓药业-B、凯莱英涨幅较大,振幅较大的相关个股有德琪医药-B、凯莱英、宝济药业-B,振幅分别为9.72%、8.12%、6.67%。君圣泰医药-B公司简介:君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304095534a448f14d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304095534a448f14d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"1139747588","title":"君圣泰医药(02511)2月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1139747588","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139747588?lang=zh_cn&edition=full","pubTime":"2026-03-02 18:20","pubTimestamp":1772446840,"startTime":"0","endTime":"0","summary":"君圣泰医药3月2日公布截至2026年2月28日的股份变动月报表。本月公司注册股本与已发行股份规模保持稳定,未发生新增发行、购回或注销股份等活动。截至2026年2月28日,君圣泰医药的已发行普通股总数为571,325,668股,库藏股数为0股,合计已发行股份总数保持571,325,668股不变。本次公告由执行董事兼行政总裁刘利平博士签署。根据公告,截至2月底,公司总体股本规模未有新增或减少,未见重大变动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0},{"id":"2616804974","title":"君圣泰医药-B盘中异动 早盘大幅下跌12.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616804974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616804974?lang=zh_cn&edition=full","pubTime":"2026-03-02 09:35","pubTimestamp":1772415345,"startTime":"0","endTime":"0","summary":"2026年03月02日早盘09时35分,君圣泰医药-B股票出现波动,股价大幅下挫12.99%。君圣泰医药-B股票所在的药品行业中,整体跌幅为0.63%。其相关个股中,海西新药、劲方医药-B、海王英特龙涨幅较大,振幅较大的相关个股有宝济药业-B、君圣泰医药-B、劲方医药-B,振幅分别为10.26%、8.66%、6.42%。君圣泰医药-B公司简介:君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030209354597a78f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030209354597a78f05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2614015633","title":"君圣泰医药-B02月26日主力净流出27.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614015633","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614015633?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:15","pubTimestamp":1772093731,"startTime":"0","endTime":"0","summary":"02月26日, 君圣泰医药-B股价跌4.15%,报收2.31元,成交金额186.7万元,换手率0.14%,振幅7.05%,量比2.08。君圣泰医药-B今日主力资金净流出27.5万元,上一交易日主力净流出0万元。该股近5个交易日下跌8.70%,主力资金累计净流出68.3万元;近20日主力资金累计净流出72.4万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226161715a7218675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226161715a7218675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2611318186","title":"每日卖空追踪 | 君圣泰医药-B 02月12日卖空量成交2.8万股,卖空比例为13.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611318186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611318186?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:30","pubTimestamp":1770885031,"startTime":"0","endTime":"0","summary":"君圣泰医药-B北京时间02月12日,跌1.9%,卖空量成交2.8万股,较上一交易日增加1766.67%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163438a6f28cdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212163438a6f28cdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2610263551","title":"每日卖空追踪 | 君圣泰医药-B 02月09日卖空量成交2500股,卖空比例为1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610263551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610263551?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625831,"startTime":"0","endTime":"0","summary":"君圣泰医药-B北京时间02月09日,跌0.75%,卖空量成交2500股,较上一交易日减少88.37%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163851a48e5d26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163851a48e5d26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2610687626","title":"CKM治疗新纪元:君圣泰医药-B(2511.HK)“一药多效”战略迎来价值重估关键节点","url":"https://stock-news.laohu8.com/highlight/detail?id=2610687626","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610687626?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:10","pubTimestamp":1770624638,"startTime":"0","endTime":"0","summary":"君圣泰医药的探索,超越了单一药物的成功,它昭示着中国创新药企正在全球舞台上从“跟随者”向“范式定义者”演进。","market":"sh","thumbnail":"https://img2.gelonghui.com/b17e2-50bf98fa-64a4-49f5-a741-87a0f9b5f941.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-50bf98fa-64a4-49f5-a741-87a0f9b5f941.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3803619","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2609276983","title":"君圣泰医药-B(02511)完成HTD1801治疗代谢相关脂肪性肝炎的 IIb期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2609276983","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609276983?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:59","pubTimestamp":1770281957,"startTime":"0","endTime":"0","summary":"智通财经APP讯,君圣泰医药-B 发布公告,HTD1801在代谢相关脂肪性肝炎患者中开展的全球多中心IIb期临床研究已完成。该结果大幅高于既往同类临床研究中的安慰剂效应。HTD1801在该研究中展现出的长期安全性与耐受性与既往临床研究结果一致。鉴于HTD1801此前在合并T2DM的MASH患者中开展的IIa期临床研究,以及其在 T2DM患者人群中完成的3项临床III期研究中,均成功达主要终点,呈现多重获益且顺利推进NDA。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2608363563","title":"每日卖空追踪 | 君圣泰医药-B 02月03日卖空量成交1.3万股,卖空比例为3.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608363563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608363563?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:30","pubTimestamp":1770107431,"startTime":"0","endTime":"0","summary":"君圣泰医药-B北京时间02月03日,跌1.9%,卖空量成交1.3万股,较上一交易日减少25.71%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163526a476c316&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163526a476c316&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2608336330","title":"君圣泰医药-B02月03日主力净流出21.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608336330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608336330?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:15","pubTimestamp":1770106557,"startTime":"0","endTime":"0","summary":"02月03日, 君圣泰医药-B股价跌1.90%,报收2.58元,成交金额104.2万元,换手率0.07%,振幅3.42%,量比1.23。君圣泰医药-B今日主力资金净流出21.3万元,上一交易日主力净流出0万元。该股近5个交易日下跌6.18%,主力资金累计净流出1.9万元;近20日主力资金累计净流入77.1万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203162306a6cda963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203162306a6cda963&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"1130193880","title":"君圣泰医药(02511)更新2026年1月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1130193880","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130193880?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:57","pubTimestamp":1770022644,"startTime":"0","endTime":"0","summary":"2026年2月2日,君圣泰医药发布2026年1月股份变动月报表。公告显示,截至2026年1月31日,公司注册股本及已发行股份数量均未发生变化。截至报告期末,公司确认符合香港联合交易所有限公司相关上市规则保持的最低公众持股量要求。本次月报由公司执行董事兼行政总裁刘利平博士签署。公司表示,将持续严格遵守香港联交所《上市规则》及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02511"],"gpt_icon":0},{"id":"2608859088","title":"君圣泰医药-B(02511)任命Filip Surmont博士为首席医学官 强化心肾代谢系统疾病(CKM)布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2608859088","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608859088?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:39","pubTimestamp":1770021551,"startTime":"0","endTime":"0","summary":"智通财经APP讯,君圣泰医药-B(02511)发布公告,任命Filip Surmont博士为首席医学官,全面负责公司的医学战略、临床开发及相关医学事务,助力公司核心管线在心肾代谢系统疾病(CKM)领域的研发进展与价值提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"君圣泰医药-B(02511)任命Filip Surmont博士为首席医学官 强化心肾代谢系统疾病(CKM)布局","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02511","BK1161"],"gpt_icon":0},{"id":"2607775820","title":"君圣泰医药-B盘中异动 急速下跌7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607775820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607775820?lang=zh_cn&edition=full","pubTime":"2026-01-29 09:31","pubTimestamp":1769650284,"startTime":"0","endTime":"0","summary":"2026年01月29日早盘09时31分,君圣泰医药-B股票出现异动,股价急速下挫7.61%。君圣泰医药-B股票所在的药品行业中,整体涨幅为0.14%。其相关个股中,长风药业、英硅智能、东瑞制药涨幅较大,振幅较大的相关个股有君圣泰医药-B、康臣药业、英硅智能,振幅分别为7.61%、3.82%、3.18%。君圣泰医药-B公司简介:君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多标靶疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129093124953ed00c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129093124953ed00c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2606273855","title":"每日卖空追踪 | 君圣泰医药-B 01月27日卖空量成交1000股,卖空比例为0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606273855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606273855?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502634,"startTime":"0","endTime":"0","summary":"君圣泰医药-B北京时间01月27日,跌1.79%,卖空量成交1000股,较上一交易日减少33.33%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164106a45b3ed1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164106a45b3ed1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02511"],"gpt_icon":0},{"id":"2604198912","title":"君圣泰医药-B01月16日主力净流入23.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2604198912","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604198912?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:15","pubTimestamp":1768551337,"startTime":"0","endTime":"0","summary":"01月16日, 君圣泰医药-B股价涨1.43%,报收2.84元,成交金额168.7万元,换手率0.11%,振幅3.57%,量比0.82。君圣泰医药-B今日主力资金净流入23.2万元,上一交易日主力净流出0万元。该股近5个交易日上涨4.80%,主力资金累计净流入23.2万元;近20日主力资金累计净流入101.1万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116161906a4cb23c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116161906a4cb23c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02511","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hightidetx.com","stockEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":0.2095},{"period":"3month","weight":0.1679},{"period":"6month","weight":-0.3014},{"period":"1year","weight":0.8545},{"period":"ytd","weight":0.0373}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.0161},{"period":"6month","weight":-0.0478},{"period":"1year","weight":0.0437},{"period":"ytd","weight":-0.0138}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"君圣泰医药是一家生物制药公司,专注于就代谢及消化系统疾病的治疗发现、开发及商业化多功能及多靶点疗法。该公司自主开发了多个候选产品的产品管线,涵盖代谢和消化疾病的多种适应症,其中部分产品处于临床阶段。该公司的核心产品HTD1801(小檗碱熊去氧胆酸盐)是一种新分子实体,作为肠肝抗炎代谢调节剂,靶向调节对人体代谢过程中至关重要的多个通路,包括与代谢及消化系统疾病相关的通路。该公司在美国、中国大陆、香港和澳大利亚开展业务。","exchange":"SEHK","name":"君圣泰医药-B","nameEN":"HIGHTIDE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君圣泰医药-B,02511,君圣泰医药-B股票,君圣泰医药-B股票老虎,君圣泰医药-B股票老虎国际,君圣泰医药-B行情,君圣泰医药-B股票行情,君圣泰医药-B股价,君圣泰医药-B股市,君圣泰医药-B股票价格,君圣泰医药-B股票交易,君圣泰医药-B股票购买,君圣泰医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君圣泰医药-B(02511)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君圣泰医药-B(02511)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}